Semaglutide operates on a molecular level by targeting the glucagon-like peptide-1 (GLP-1) receptor
Brain cells are particularly susceptible, owing to their low antioxidant defences and high oxidative metabolic activity
Chen Y, Wang G, Chen J, Wang C, Dong X, Chang HM, Yuan S, Zhao Y, Mu L (2024) Genetic and epigenetic landscape for drug development in polycystic ovary syndrome
"They are seeking a treatment with GLP-1 drugs that will likely accelerate bone loss even more." GLP-1 drugs linked to boosting testosterone, sperm count in men Postmenopausal women already lose bone faster than usual, and now many are adding a drug that speeds up weight loss, which can cause bone loss
Evidencias recientes amplan las acciones cardioprotectoras de GLP-1 a condiciones patolgicas diferentes del IM o de la IC
Cagrilintide then joins once the Retatrutide rhythm is established, introduced at a modest weekly amount and raised only if appetite control starts to feel incomplete